Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company? Seeking Alpha OB) Avastin (bevacizumab), Herceptin (trastuzumab), Rituxan (rituximab), and Zelboraf (vemurafenib). This article is the first of three articles about Array. This article looks at Array's promising collaborations with some of the biggest names in the ... |
